| Income Statement |
| Operating Expenses | 7.49M |
|
| Research and Development Expense | 4.70M |
| Selling, General and Administrative Expense | 2.52M |
| Operating Income | -7.49M |
| Net Income | -7.35M |
| Net Income Common Stock | -7.35M |
| Net Income Common Stock (USD) | -5.18M |
| Consolidated Income | -7.35M |
| Earnings per Basic Share | -0.11 |
| Earnings per Basic Share (USD) | -0.08 |
| Earnings per Diluted Share | -0.11 |
| Earning Before Interest & Taxes (EBIT) | -7.35M |
| Earning Before Interest & Taxes (USD) | -5.18M |
| Weighted Average Shares | 67.13M |
| Weighted Average Shares Diluted | 67.13M |
| Balance Sheet |
| Cash and Equivalents | 23.07M |
| Cash and Equivalents (USD) | 16.25M |
| Trade and Non-Trade Receivables | 371.19K |
| Current Assets | 25.24M |
| Property, Plant & Equipment Net | 16.92M |
| Total Assets | 42.28M |
| Current Liabilities | 2.84M |
| Total Liabilities | 2.84M |
| Accumulated Retained Earnings (Deficit) | -85.16M |
| Shareholders Equity | 39.45M |
| Shareholders Equity (USD) | 27.78M |
| Assets Non-Current | 17.04M |
| Trade and Non-Trade Payables | 2.84M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 8.84K |
| Net Cash Flow from Financing | 254.04K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.36M |
| Capital Expenditure | -2.54M |
| Issuance (Purchase) of Equity Shares | 254.04K |
| Net Cash Flow from Investing | -2.67M |
| Net Cash Flow - Investment Acquisitions and Disposals | -31.70K |
| Net Cash Flow from Operations | -6.94M |
| Effect of Exchange Rate Changes on Cash | -2.43K |
| Share Based Compensation | 262.99K |